ARAPL Joins NSE: Revolutionizing Robotics and Automation
Affordable Robotic and Automation Limited (ARAPL) marked a significant achievement by listing on the NSE, transitioning from the BSE SME Exchange. With a 900% growth in six years, ARAPL emphasizes advancement in the robotics sector. The event included remarks from key leaders, reflecting on its promising expansion into global markets.
- Country:
- India
Mumbai, India – Affordable Robotic and Automation Limited (ARAPL) achieved a major milestone by listing on the National Stock Exchange (NSE) after transitioning from the BSE SME Exchange to the BSE Main Board. The company, initially priced at ₹85 per share on the BSE SME Exchange in June 2018, now boasts a market cap of over INR 850 crores, marking a 900% growth in six years. ARAPL's success reinforces its stature in robotics and automation, presenting itself as a leader in innovative solutions.
The listing ceremony highlighted the presence of distinguished figures such as Mr. Ashish Chouhan, MD of NSE, Sriram Krishnan, CBDO at NSE, and Vijay Kedia, an influential investor. ARAPL's Founder and MD, Mr. Milind Padole, expressed his gratitude on the occasion, emphasizing the company's potential for continued growth. With strategic expansions in the USA and Europe, ARAPL is poised to reach new heights and expand its technological expertise and global reach.
The company's leadership emphasized scaling production and meeting increasing global demand with future-oriented manufacturing and innovative solutions. With a firm foundation, clear vision, and commitment to innovation and customer satisfaction, ARAPL stands prepared to lead the automation sector, promising enhanced value for stakeholders worldwide.
(With inputs from agencies.)
- READ MORE ON:
- ARAPL
- robotics
- automation
- NSE
- stock exchange
- IPO
- global markets
- Mumbai
- Vijay Kedia
- growth
ALSO READ
India's Strategic Shift: Embracing a Multipolar World
Unlocking Success: Indian Venture IPO & Exit Strategies Forum 2024
Global Markets Reacts to Financial Updates and Policies
Evexia Lifecare Acquires Major Stake in Regenerative Medicine Pioneer Diponed Bio
Global Markets Face Uncertainty Amid Political Tensions